Principles and strategies for monitoring home parenteral nutrition

Nutrition in Clinical Practice

Volumn 22, Issue 3, 2007, Pages 340-350

  Siepler, John ^a  

^a Nutrishare Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; IRON; LIPID EMULSION; LOPERAMIDE; MAGNESIUM; MANGANESE; NARCOTIC AGENT; PHOSPHORUS; POTASSIUM; RETINOL; VITAMIN D; WARFARIN; ZINC;

ANEMIA; BLOODSTREAM INFECTION; BODY WEIGHT; BRAIN DISEASE; CATHETER INFECTION; CATHETER THROMBOSIS; COPPER DEFICIENCY; DAILY LIFE ACTIVITY; DEHYDRATION; DISORDERS OF ACID BASE BALANCE; DUAL ENERGY X RAY ABSORPTIOMETRY; ECONOMIC ASPECT; ELECTROLYTE DISTURBANCE; ENDOCARDITIS; FOLIC ACID DEFICIENCY; HEPATOMEGALY; HOME CARE; HOSPITAL DISCHARGE; HUMAN; HYPERVOLEMIA; HYPONATREMIA; LABORATORY TEST; LIVER DISEASE; LOW DRUG DOSE; METABOLIC BONE DISEASE; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PATIENT MONITORING; REVIEW; SEPSIS; SMALL INTESTINE DISEASE; UREA NITROGEN BLOOD LEVEL; ZINC DEFICIENCY; BLOOD ANALYSIS; METHODOLOGY; PATIENT CARE; PATIENT SELECTION; QUALITY OF LIFE; SAFETY; TIME; TREATMENT OUTCOME;

BLOOD CHEMICAL ANALYSIS; HUMANS; PARENTERAL NUTRITION, HOME; PATIENT CARE TEAM; PATIENT SELECTION; QUALITY OF LIFE; SAFETY; TIME FACTORS; TREATMENT OUTCOME;

EID: 34347218638     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0115426507022003340     Document Type: Review

References (51)

1. A.S.P.E.N. Board of Directors and the Standards for Specialized Nutrition Support Task Force; Kovacevich DS, Frederick A, Kelly D, Nishikawa RA, Young L. Standards for specialized nutrition support: home care patients. Nutr Clin Pract. 2005;20:579-590.
2. Messing B, Joly F. Guidelines for management of home parenteral support in adult chronic intestinal failure patients. Gastroenterology. 2006;130(2 suppl 1):S43-S51.
3. A.S.P.E.N. Board of Directors and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr 2002;26(1 suppl):1SA-138SA. Errata, 2002;26:144.
4. Seres DS. Surrogate nutrition markers, malnutrition, and adequacy of nutrition support. Nutr Clin Pract. 2005;20:308-313.
5. Jeppesen PB, Mortensen PB. Intestinal failure defined by measurements of intestinal energy and wet weight absorption. Gut. 2000;46:701-706.
6. Koretz RL, Lipman TO, Klein S. A technical review of parenteral nutrition. Gastroenterology. 2001;121:970-1001.
7. Howard L. Home parenteral nutrition: survival, cost, and quality of life. Gastroenterology. 2006;130(2 suppl 1):S52-S59.
8. Ugur A, Marashdeh BH, Gottschalck I, Brobech Mortensen P, Staun M, Bekker Jeppesen P. Home parenteral nutrition in Denmark in the period from 1996-2001. Scand J Gastroenterol. 2006;41:401-407.
9. Lauverjat M, Hadj Aissa A, Vanhems P, Bouletreau P, Fouque D, Chambrier C. Chronic dehydration may impair renal function in patients with chronic intestinal failure on long term parenteral nutrition. Clin Nutr. 2006;25:75-81.
10. Duerksen DR, Papineau N, Siemens J, Yaffe C. Peripherally inserted central catheters for parenteral nutrition: a comparison with centrally inserted catheters. JPEN J Parenter Enteral Nutr. 1999;23:85-89.
11. Yildizeli B, Lacin T, Batirel HF, Yuksel M. Complications and management of long-term central venous access catheters and ports. J Vasc Access. 2004;5:174-178.
12. Skandalos I, Hatzibaloglou A, Evagelou I, et al. Deviations of placement/function of permanent central vein catheters for hemodialysis. Int J Artif Organs. 2005;28:583-586.
13. Schwarz RE, Coit DG, Groeger JS. Transcutaneously tunneled central venous lines in cancer patients: an analysis of devicerelated morbidity factors based on prospective data collection. Am Surg Oncol. 2000;7:441-449.
14. Gould JR, Carloss HW, Skinner WL. Groshong catheter-associated subclavian catheter thrombosis. Am J Med. 1993;95:419-423.
15. Bern MM, Lokich JJ, Wallach SR, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters: a randomized prospective trial. Ann Intern Med. 1990;112:421-428.
16. Banton J. Techniques to prevent central venous catheter infections: products, research, and recommendations. Nutr Clin Pract. 2006;21:56-61.
17. Cowl CT, Weinstock JV, Al-Jurf A, Ephgrave K, Murray JA, Dillon K. Complications associated with parenteral nutrition delivered to hospitalized patients through either subclavian or peripherally inserted central catheters. Clin Nutr. 2000;19:237-243.
18. Farr BM. Preventing vascular catheter-related infections: current controversies. Clin Infect Dis. 2001;33:1733-1738.
19. Mermel LA, Farr BM, Sherertz RJ, et al; Infectious Diseases Society of America, American College of Critical Care Medicine, Society for Healthcare Epidemiology of America. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001;32:1249-1272.
20. Buchman AL. Etiology and initial management of short bowel syndrome. Gastroenterology. 2006;130(suppl 2):S5-S15.
21. Newton AF, DeLegge MH. Home initiation of parenteral nutrition. Nutr Clin Pract. 2007;22:57-64.
22. Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003;31:359-366. (Pubitemid 36232926)
23. Kelly DA. Intestinal failure-associated liver disease: what do we know today? Gastroenterology. 2006;130(2 suppl 1):S70-S77.
24. Quigley EM, Quera R. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology. 2006;130(2 suppl 1):S78-S90.
25. Riordan SM, Mclver CJ, Thomas DH, et al. Luminal bacterial and small-intestinal permeability. Scand J Gastroenterol. 1997;32:556-563.
26. Carbonnel F, Cosnes J, Chevret S, et al. The role of anatomic factors in nutritional anatomy after extensive small bowel resection. JPEN J Parenter Enteral Nutr. 1996;20:275-280.
27. Riordan SM, McIver CJ, Wakefield D, Duncombe VM, Bolin TD, Thomas MC. Mucosal cytokine production in small-intestinal bacterial overgrowth. Scand J Gastroenterol. 1996;31:977-984. (Pubitemid 26338295)
28. OKeefe SJ. Bacterial overgrowth and liver complications in short bowel intestinal failure patients. Gastroenterology. 2006;130(2 suppl 1):S67-S69.
29. Dibaise JK, Young RJ, Vanderhoof JA. Enteric microbial flora, bacterial overgrowth, and short-bowel syndrome. Clin Gastroenterol Hepatol. 2006;4:11-20.
30. Nightingale JM. The medical management of intestinal failure: methods to reduce the severity. Proc Nutr Soc. 2003;62:703-710.
31. Parrish CR. The clinician's guide to short bowel syndrome. Prac Gastroenterol. 2005;(Sept):67-106.
32. Cavicchi M, Beau P, Crenn P, Degott C, Messing B. Prevalence of liver disease and permanent intestinal failure. Ann Intern Med. 2000;132:525-532.
33. Btaiche IF, Khalidi N. Parenteral nutrition-associated liver complications in children. Pharmacotherapy. 2002;22:188-211.
34. Kumpf VJ. Parenteral nutrition-associated liver disease in adult and pediatric patients. Nutr Clin Pract. 2006;21:279-290.
35. Henkel AS, Buchman AL. Nutritional support in patients with chronic liver disease. Nat Clin Pract Gastroenterol Hepatol. 2006;3:202-209.
36. Buchman AL, Iyer K, Fryer J. Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation. Hepatology. 2006;43:9-19.
37. Buchman AL, Moukarzel A. Metabolic bone disease associated with total parenteral nutrition. Clin Nutr. 2000;19:217-231.
38. Hurley DL, McMahon M. Long term parenteral nutrition and metabolic bone disease. Endocrinol Metab Clin North Am. 1990;19:113-131.
39. Pironi L, Tjellesen L, De Francesco A, et al; ESPEN-Home Artificial Nutrition Working Group. Bone mineral density in patients on home parenteral nutrition: a follow-up study. Clin Nutr. 2004;23:1288-1302.
40. Schoon EJ, Bollani S, Mills PR, et al; Matrix Study Group. Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease. Clin Gastroenterol Hepatol. 2005;3:113-121.
41. Howard L, Chu R, Feman S, Mintz H, Ovesen L, Wolf B. Vitamin A deficiency from long-term parenteral nutrition. Ann Intern Med. 1980;93:576-577.
42. Wolman SL, Anderson GH, Marliss EB, Jeejeebhoy KN. Zinc in total parenteral nutrition: requirements and metabolic effects. Gastroenterology. 1979;76:458-467.
43. Hoque KM, Binder HJ. Zinc in the treatment of acute diarrhea: current status and assessment. Gastroenterology. 2006;130:2201-2205.
44. Wolman SL, Anderson GH, Marliss EB, Jeejeebhoy KN. Zinc in total parenteral nutrition: requirements and metabolic effects. Gastroenterology. 1979;76:458-476.
45. Dickerson RN. Manganese intoxication and parenteral nutrition. Nutrition. 2001;17:689-693.
46. Siepler JK, Nishikawa RA, Diamantidis T, Okamoto R. Asymptomatic hypermanganesemia in long-term home parenteral nutrition patients. Nutr Clin Pract. 2003;18:370-373.
47. Spiegel JE, Willenbucher RF. Rapid development of severe copper deficiency in a patient with Crohn's disease receiving parenteral nutrition. JPEN J Parenter Enteral Nutr. 1999;23:169-172.
48. Blaszyk H, Wild PJ, Oliveira A, Kelly DG, Burgart LJ. Hepatic copper in patients receiving long-term total parenteral nutrition. J Clin Gastroenterol. 2005;39:318-320.
49. Hurwitz M, Garcia MG, Poole RL, Kerner JA. Copper deficiency during parenteral nutrition: a report of four pediatric cases. Nutr Clin Pract. 2004;19:305-308.
50. Svensson E. Construction of a single global scale for multi-item assessments of the same variable. Stat Med. 2001;20:3831-3846.
51. Siepler JK, Nishikawa RA, Diamantidis T, Okamoto R. Quality of life in home parenteral nutrition patients is improved in patients who use a specialty home care provider [abstract]. Clin Nutr. 2003;22:S89.